In this issue of Neuron, Grayson et al. (2016) report how inhibition of amygdala impacts amygdalocortical and corticocortical functional connectivity. Their study predicts changes in functional brain topology, induced by pharmacologic modulation of neuroanatomical circuits using designer receptors exclusively activated by designer drugs (DREADDs), through virtual lesioning of amygdala in structural brain networks.
Keywords: DREADDs; functional brain network; network neuroscience; structural brain network; virtual lesioning.
Copyright © 2016 Elsevier Inc. All rights reserved.